Woodstock Corp Lowers Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Woodstock Corp lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.5% during the second quarter, HoldingsChannel reports. The firm owned 97,123 shares of the medical equipment provider’s stock after selling 1,526 shares during the period. Intuitive Surgical comprises approximately 3.9% of Woodstock Corp’s portfolio, making the stock its 5th biggest holding. Woodstock Corp’s holdings in Intuitive Surgical were worth $33,210,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of ISRG. Independence Bank of Kentucky bought a new stake in Intuitive Surgical during the 2nd quarter valued at $120,000. Harvest Fund Management Co. Ltd raised its holdings in Intuitive Surgical by 181.1% during the 2nd quarter. Harvest Fund Management Co. Ltd now owns 4,216 shares of the medical equipment provider’s stock valued at $1,441,000 after acquiring an additional 2,716 shares during the period. Renaissance Investment Group LLC raised its holdings in Intuitive Surgical by 0.9% during the 2nd quarter. Renaissance Investment Group LLC now owns 30,908 shares of the medical equipment provider’s stock valued at $10,569,000 after acquiring an additional 278 shares during the period. Capital Market Strategies LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at $351,000. Finally, Glassy Mountain Advisors Inc. purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at $295,000. Institutional investors own 82.91% of the company’s stock.

Insider Buying and Selling

In related news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $310.00, for a total value of $620,000.00. Following the completion of the transaction, the director now directly owns 25,319 shares of the company’s stock, valued at $7,848,890. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $310.00, for a total value of $620,000.00. Following the completion of the transaction, the director now directly owns 25,319 shares of the company’s stock, valued at $7,848,890. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Gary S. Guthart sold 4,960 shares of the stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $325.89, for a total transaction of $1,616,414.40. Following the completion of the transaction, the chief executive officer now directly owns 32,320 shares of the company’s stock, valued at $10,532,764.80. The disclosure for this sale can be found here. Insiders sold a total of 59,809 shares of company stock valued at $19,496,481 over the last three months. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of recent analyst reports. StockNews.com initiated coverage on shares of Intuitive Surgical in a research report on Thursday, August 17th. They set a “buy” rating for the company. Raymond James boosted their price target on shares of Intuitive Surgical from $323.00 to $368.00 and gave the company an “outperform” rating in a research report on Monday, July 24th. TheStreet upgraded shares of Intuitive Surgical from a “c+” rating to a “b” rating in a research report on Monday, July 24th. Robert W. Baird began coverage on shares of Intuitive Surgical in a research report on Tuesday, July 18th. They issued an “outperform” rating and a $377.00 target price for the company. Finally, Mizuho upped their target price on shares of Intuitive Surgical from $300.00 to $370.00 in a research report on Monday, July 17th. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $343.10.

Intuitive Surgical Stock Down 1.4 %

Shares of NASDAQ:ISRG traded down $4.21 during midday trading on Friday, hitting $299.53. 646,153 shares of the stock traded hands, compared to its average volume of 1,693,507. The stock has a market capitalization of $105.25 billion, a PE ratio of 76.13, a P/E/G ratio of 4.25 and a beta of 1.30. The business’s 50 day moving average is $315.80 and its two-hundred day moving average is $296.60. Intuitive Surgical, Inc. has a one year low of $180.07 and a one year high of $358.07.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $1.42 EPS for the quarter, beating the consensus estimate of $1.33 by $0.09. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Intuitive Surgical had a net margin of 21.38% and a return on equity of 12.41%. The company’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.85 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 4.53 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.